Ticker: AKTX

Company: Akari Therapeutics Plc

Person: Kameel D Farag, officer

Transaction date: Aug. 17, 2026

Reporting date: Aug. 19, 2026

Average share price: 7.52

Bought 1728.0 shares for 12994.56